Re: Separation from EmploymentSeparation Agreement • May 9th, 2019 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
This confidential separation agreement and release (“Agreement”) sets forth the agreement reached concerning the termination of your employment with Immunomedics, Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 9th, 2019 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement") is entered into effective as of the 7th day of August, 2017 (the "Effective Date") by and between Immunomedics, Inc., a Delaware corporation having its principal offices in Morris Plains, New Jersey (the "Company," which term shall include all respective subsidiaries, affiliates, and entities of the Company, and its and their respective successors and assigns), and Usama Malik (the "Executive").
March 7, 2019 Dear Scott,Executive Director Agreement • May 9th, 2019 • Immunomedics Inc • In vitro & in vivo diagnostic substances
This letter agreement (this “Agreement”), which shall be effective as of March 5, 2019 (the “Effective Date”), sets forth the terms of your appointment as Executive Director of Immunomedics, Inc. (the “Company”), which was effective as of February 23, 2019. As Executive Director, you will be expected to perform your duties as a member of the Board of Directors of the Company (the “Board”) as well as consult with and advise the Company’s management team at the request of the Board from time to time with respect to your knowledge, experience and expertise. This will include (1) assisting the Company’s management team with resolving the issues identified in the Complete Response Letter received from the U.S. Food and Drug Administration (the “FDA”) related to the Biologics License Application (“BLA”) seeking accelerated approval of sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic
